Takeda Pharmaceutical Company Limited (TAK)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 02:06PM EDT. Market open.
| Previous Close | 13.05 |
| Open | 13.35 |
| Bid | 13.56 x 4000 |
| Ask | 13.57 x 1800 |
| Day's Range | 13.34 - 13.60 |
| 52 Week Range | 12.75 - 16.15 |
| Volume | |
| Avg. Volume | 2,473,165 |
| Market Cap | 42.197B |
| Beta (5Y Monthly) | 0.79 |
| PE Ratio (TTM) | 30.85 |
| EPS (TTM) | 0.44 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.73 (5.60%) |
| Ex-Dividend Date | Mar 30, 2022 |
| 1y Target Est | 17.64 |
- Business Wire
Strengthening Healthcare Systems to Meet Patients’ Need for Plasma-Derived Therapies
OSAKA, Japan, & GENEVA, Switzerland, September 29, 2022--As part of their well-established partnership, the United Nations Institute for Training and Research (UNITAR) and Takeda (TSE:4502/NYSE:TAK), a global pharmaceutical leader and an active member of the United Nations Global Compact, are pleased to announce a new joint initiative focused on strengthening countries’ healthcare systems to meet patients’ need for plasma and plasma-derived therapies. The initiative will draw on UNITAR’s experti
- Zacks
TAK vs. ZTS: Which Stock Should Value Investors Buy Now?
TAK vs. ZTS: Which Stock Is the Better Value Option?
- Zacks
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib
Puma Biotechnology (PBYI) inks license agreement with Japan's Takeda Pharmaceuticals, gaining worldwide development and commercialization rights to the latter's cancer treatment alisertib.
© 2022 Yahoo. All rights reserved.
